M. A. Mnaili

Clinical Efficacy and Safety of Fingolimod in Relapsing-Remitting Multiple Sclerosis : A 10-Year Single-Centre Retrospective Observational Study

Hajar Belghacham, S. Slimani, K. Hjiej, M. Bourrouk, S. Ouzegza, I. Beogo, M. A. Mnaili, Y. Benmoh & A. Bourazza · Asian Journal of Research and Reports in Neurology · 2026

Background: Fingolimod is an oral disease-modifying therapy approved for the treatment of highly active relapsing forms of multiple sclerosis (MS). Real-world data remain essential for assessing its long-term effectiveness and safety in routine clinical practice. Objective: The s...